" class="no-js "lang="en-US"> Cardiovascular Archives - Page 2 of 9 - Medtech Alert
Thursday, March 30, 2023

Sort by:


Top Post

UltraSight Receives CE Mark for Novel Cardiac AI Technology

UltraSight, an Israeli-based digital health pioneer transforming cardiac imaging through the power of artificial intelligence, […]

£30m for Scientists to Rewrite DNA to Cure Killer Heart Diseases

An injectable cure for inherited heart muscle conditions that can kill young people in the […]

Caption Health and Heartbeat Health Partner to Provide Unprecedented Access to Cardiac Care

Caption Health, the leader in providing services and AI to improve heart ultrasound access, and […]

Acticor Biotech Obtains "PRIME" Status From the European Medicines Agency for Glenzocimab in the Treatment of Stroke

ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT), a clinical-stage biotechnology company developing innovative drugs for the […]

Retia Medical Raises $15 Million to Accelerate Commercialization of the Argos Hemodynamic Monitor

Retia Medical, an innovator in advanced hemodynamic monitoring, today announced that it has secured $15 million in […]

Ai-powered Drug Discovery Company Healx Opens New Labs at Chesterford Research Park

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery for rare […]

Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care

Novartis Pharmaceuticals UK announces the launch of the Novartis Biome UK Heart Health Catalyst 2022, […]

Centerline Biomedical Raises $33 Million in Series B Financing

Centerline Biomedical, Inc. (Centerline), a private medical technology company, announced the closing of a $33 million Series […]

New Understanding of Congenital Heart Disease Progression Opens Door to Improved Treatment Options

A team of investigators from Texas Heart Institute, Texas Children’s Hospital and Baylor College of Medicine uncovered […]

Elucid Raises $27 Million Series B Funding Round to Commercialize a New Paradigm in Heart Disease Diagnosis

Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced […]

  1. Glyscend Therapeutics Appoints Biotech Industry Veteran Michael Wyzga to its Board of Directors Read more
  2. Trobix Bio Raises $3 Million from Chartered Group to Advance Precision Microbiome Oncology Therapeutics Read more
  3. Mathai Mammen to Join FogPharma as Chairman, President and Chief Executive Officer Read more
  4. Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases Read more
  5. Implantica Launches RefluxStop™ in Italy Read more